151 related articles for article (PubMed ID: 4035232)
1. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E
Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
[TBL] [Abstract][Full Text] [Related]
3. [Erythrocyte filterability and treatment with pentoxifylline].
Valentini M; Sciannameo F; Francucci M; Tockner M; Sassano L; Allegra A
Ric Clin Lab; 1983; 13 Suppl 3():455-8. PubMed ID: 6673029
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy.
Solerte SB; Fioravanti M; Patti AL; Schifino N; Zanoletti MG; Inglese V; Ferrari E
Acta Diabetol Lat; 1987; 24(3):229-39. PubMed ID: 3687315
[TBL] [Abstract][Full Text] [Related]
5. Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
Solerte SB; Ferrari E
Pharmatherapeutica; 1985; 4(6):341-50. PubMed ID: 4080752
[TBL] [Abstract][Full Text] [Related]
6. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study.
Solerte SB; Fioravanti M; Bozzetti A; Schifino N; Patti AL; Fedele P; Viola C; Ferrari E
Acta Diabetol Lat; 1986; 23(2):171-7. PubMed ID: 3751450
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the long-term prophylactic use of trental on cerebral blood flow in diabetics].
Nazarova KhI
Klin Med (Mosk); 1988 Sep; 66(9):85-7. PubMed ID: 3204970
[No Abstract] [Full Text] [Related]
9. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
10. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
Antignani PL; Todini AR; Saliceti F; Pacino G; Bartolo M
Pharmatherapeutica; 1987; 5(1):50-6. PubMed ID: 3602022
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
[TBL] [Abstract][Full Text] [Related]
12. [Sudden deafness: apropos of 19 cases. Results of treatment with pentoxifylline. Value of erythrocyte filtration time].
Denis F; Ketari M; Benzaken J; Renou G
Ann Otolaryngol Chir Cervicofac; 1989; 106(1):21-6. PubMed ID: 2719437
[TBL] [Abstract][Full Text] [Related]
13. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M
Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline and intermittent claudication.
Reilly DT
N Z Med J; 1987 Oct; 100(833):640. PubMed ID: 3452126
[No Abstract] [Full Text] [Related]
15. Pentoxifylline and intermittent claudication.
Simpson LO
N Z Med J; 1987 Aug; 100(830):539. PubMed ID: 3452096
[No Abstract] [Full Text] [Related]
16. Pentoxifylline and intermittent claudication.
Simpson LO
N Z Med J; 1987 Nov; 100(835):693. PubMed ID: 3452154
[No Abstract] [Full Text] [Related]
17. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
18. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
Cummings DM; Ballas SK
Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
[TBL] [Abstract][Full Text] [Related]
19. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
J Med; 1988; 19(2):67-88. PubMed ID: 3171402
[TBL] [Abstract][Full Text] [Related]
20. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
